Filter by

Location

more »

Company

more »

We've found 6 jobs for you

teksystems  •  2026-04-18
  Boston, US

Hybrid Market Access Strategy Specialist - US Payer Expert

A leading biotechnology firm in Boston is seeking a Market Access Strategy Specialist to develop strategies for market access for approved medicines and pipeline programs. The ideal candidate should have a bachelors degree with 8+ years in marketing within the…

teksystems  •  2026-04-17
  Boston, US

Market Access Strategy Specialist

Description Our client currently operates at the forefront of rare disease scientific innovation and has successfully developed and commercialized multiple breakthrough medicines for Cystic Fibrosis (CF), Sickle Cell Disease and Transfusion-Dependent Beta Thal…

teksystems  •  2026-04-18
  Boston, US

Hybrid Market Access Strategy Specialist - US Payer Expert

A leading biotechnology firm in Boston is seeking a Market Access Strategy Specialist to develop strategies for market access for approved medicines and pipeline programs. The ideal candidate should have a bachelors degree with 8+ years in marketing within the…

teksystems  •  2026-04-17
  Boston, US

Market Access Strategy Specialist

Description Our client currently operates at the forefront of rare disease scientific innovation and has successfully developed and commercialized multiple breakthrough medicines for Cystic Fibrosis (CF), Sickle Cell Disease and Transfusion-Dependent Beta Thal…

TEKsystems  •  2026-04-19
  Boston, MA, US

Hybrid Market Access Strategy Specialist - US Payer Expert

A leading biotechnology firm in Boston is seeking a Market Access Strategy Specialist to develop strategies for market access for approved medicines and pipeline programs. The ideal candidate should have a bachelors degree with 8+ years in marketing within the…

TEKsystems  •  2026-04-19
  Boston, MA, US

Market Access Strategy Specialist

Description Our client currently operates at the forefront of rare disease scientific innovation and has successfully developed and commercialized multiple breakthrough medicines for Cystic Fibrosis (CF), Sickle Cell Disease and Transfusion-Dependent Beta Thal…